Ann: Annual Report to shareholders, page-9

It's all about scalability and BCT management has been very careful and diligent during this process since the start of the first order from Labcon. Scaling up without making sure all the systems are in place to maintain quality at the highest level. Testing automation is part of it.

And it will not only be chips but also virals and all accessories that are used with the chips.

And beyond FY21, who knows were sales will be .. $20, 30,50million? Right now we are priced for $1-2m pa in perpetuity anyway..